HGF inhibits fibrotic remodeling, which is mediated by multiple direct and indirect mechanisms, including the induction of cell survival, proliferation of pulmonary epithelial and endothelial cells, and reduction of myofibroblast accumulation (162), suggesting that HGF can be used to treat pneumoconiosis. The gene discussed is HGF; the disease is pneumoconiosis.